NeuroSearch A/S : reports change of employee elected Board member

Announcement
28.01.2013

By the end of January 2013, the employee elected Board member Mads P.G. Korsgaard will resign from the Board of Directors of NeuroSearch A/S (NEUR) due to the expiration of his employment with the company.

With effect from 1 February 2013, IT Director Morten Henrik Nielsen will re-join the Board as employee elected Board member.

Morten Henrik Nielsen was employed at NeuroSearch in 1989 and was a member of the Board of Directors for some time in 2012.

René Schneider
CEO

Contact person
René Schneider, CEO, telephone: [phone] or [phone]

About NeuroSearch
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S. The company's product pipeline comprises ordopidine and seridopidine, which have both completed phase I studies, as well as tesofensine, which has completed phase II and NS2359 which has completed phase I.
All drug candidates exert their effect in the central nervous system.